MedTrace Logo

Renal Artery Contrast-Free Trial

NCT01576835 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2015-08-26

No results posted yet for this study

Summary

This study will compare the results of a clinically ordered abdominal CT angiography to a research non-contrast MR angiogram (MRA). CTA is a "gold-standard" for identifying blockages in the kidney arteries or other blood vessel problems. CTA requires radiation and contrast to obtain useful images. Conversely, the MR abdomen technique being used for the study uses no radiation or contrast and is felt to be a safer option for individuals who have kidney problems. there is benefit to establishing non-contrast MRA as a clinically accurate test.

Conditions

Sponsors & Collaborators

  • Toshiba America Medical Systems, Inc.

    collaborator INDUSTRY

  • Central Coast Cardiovascular Research

    lead OTHER

Principal Investigators

  • Timothy S. Albert, MD · Central Coast Cardiovascular Research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-11-30
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01576835 on ClinicalTrials.gov